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Summary 
Preculture of thioglycollate-elicited C3HeB/FeJ mouse peritoneal macrophages in vitro with 
subthreshold stimulatory concentrations of lipopolysaccharide (LPS) can induce hyporesponsiveness 
(desensitization)  to both tumor necrosis factor ot (TNF-cr  and nitric oxide (NO) production 
when these cells are subsequently stimulated with 100 ng/ml of LPS. We have established, however, 
that the primary dose of LPS required for inducing downreguhtion of NO production is significantly 
lower than that required for inducing downregulation of TNF-o~ production. Further, when 
LPS-pretreated macrophages become refractory to subsequent LPS stimulation for NO production, 
the secondary LPS-stimulated TNF-o~ production is markedly enhanced, and vice versa. These 
results indicate that LPS-induced TNF-c~ and NO production by macrophages are differentially 
regulated, and that the observed desensitization process may not reflect a state in which macrophages 
are totally refractory to subsequent LPS stimulation. Rather, our data suggest that LPS-pretreated 
macrophages become selectively primed for differential responses to LPS. The LPS-induced selective 
priming effects are not restricted to LPS stimulation, but extend as well to stimuli such as zymosan, 
Staphylococcus aureus, and heat-killed Listeria monocytogenes. 
E 
S, a major component of the Gram-negative bacteria cell 
wall, is well recognized for its ability to activate the host 
immune system and elicit a wide array ofpathophysiological 
effects, which can result in the development of the syndrome 
known as endotoxic shock in both human beings and animals 
(1). When stimulated in vitro by LPS, macrophages produce 
a number of cytokines and other inflammatory mediators, 
including TNF-c~ and nitric oxide (NO), both of which con- 
tribute directly to the ability of macrophages to kill invading 
bacteria  and tumor cells and to the pathogenesis of septic 
shock (2-4). 
Although it has been well established that LPS can, under 
appropriate conditions, induce a state of hyporesponsiveness 
to its own effects (5), the cellular and molecular changes that 
contribute to LPS-induced tolerance remain to be fully defined. 
Two phases of "endotoxin tolerance" have been recognized. 
First, an early-phase tolerance to the lethal activity of LPS, 
which is lipid A dependent and develops within a few hours 
after a single injection of LPS; and second, a late-phase toler- 
ance, which has O antigen specificity and is dependent upon 
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the development of specific anti-LPS antibodies in the circu- 
lation. There is increasing evidence to suggest that the in- 
duction of the early tolerance to LPS by LPS pretreatment 
is mediated primarily by macrophages or monocytes (6-8). 
Recently it has been reported that PGE2 and the protein ki- 
nase C (PKC) activator, PMA, both of which are known to 
be involved in the LPS-stimulated macrophage activation, act 
synergically to induce the LPS refractory state of macrophages, 
at least as assessed  by TNF-c~ production (9). Therefore, studies 
of the LPS-induced desensitization of macrophages may pro- 
vide important information on the biochemical mechanisms 
by which LPS activates macrophages in vitro, as well as on 
the mechanisms of LPS-induced tolerance in vivo. 
LPS-induced tolerance appears to be a complex process and 
may vary considerably in different experimental models (10). 
A recent comprehensive study by Mathison et al.  (11) has 
confirmed that subthreshold stimulatory concentrations of 
LPS could cause downregulation of the macrophage TNF-oe 
response when such cells were subsequently stimulated by 
an activating dose of LPS either in vivo or in vitro. In an- 
other study, however, the LPS-dependent expression of IL-1 
was shown not to be inhibited by preexposure of macrophages 
to low doses of LPS under conditions in which the LPS- 
stimulated TNF-a production was markedly suppressed (12). 
Elevation of intraceUular [Ca  2+ ] in response to LPS was also 
not suppressed by LPS pretreatment (13). Therefore, to more 
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analysis of additional macrophage responses to LPS stimula- 
tion may prove fruitful. In this manuscript, production of 
two macrophage-derived immune mediators, TNF-tx and NO, 
after LPS pretreatment and/or challenge, has been investigated. 
The specificity of the LPS pretreatment effects has been evalu- 
ated. Our results demonstrate that LPS pretreatment does 
not result in a true desensitization per se, but rather selec- 
tively reorients the macrophage toward a specific response 
that is manifest upon subsequent stimulation with either LPS 
or, other macrophage activators. 
Materials  and Methods 
Animals.  Female  C3HeB/FeJ mice were obtained from The 
Jackson Laboratory (Bar Harbor, ME) and used at 6-20 wk of age. 
Thioglycollate-elicited  Peritoneal  Macrophages.  1.5 ml 4% (wt/vol) 
Brewer thioglycollage (Difco Laboratories, Inc., Detroit, MI) was 
injected intraperitoneally into each mouse. 5 d later, cells  were har- 
vested by peritoneal lavage  with 5 ml of RPMI 1640 (with gluta- 
mine and 25 mM 14epes; Whittaker M. A. Bioproducts, Walkers- 
ville, MD) containing 10% heat-inactivated FCS (Intergen Co., 
Purchase, NY),  4 mM additional glutamine (JRH Biosciences, 
Lenexa, KS), 200 U/ml penicillin, and 200 U/ml streptomycin  (JRH 
Biosciences). The cells were washed once with the same medium, 
and 5  x  10  s peritoneal cells in the same culture medium were 
then added to each well of 24-well cluster plates (Costar Corp., 
Cambridge, MA). The cells were incubated overnight at 37~  in 
a humidified 5% COL incubator to allow macrophages to adhere 
to the plates. The plates were then washed twice with 0.5 ml HBSS 
without Ca  2+  and Mg  2§  (JRH Biosciences) to remove nonad- 
herent cells. 
Stimulation of Macrophages.  Escherichia  coli 0111:B4 smooth LPS 
(S-LPS) was prepared as the lipid A-rich fraction II of phenol- 
extracted E. coli 0111:B4 in our laboratory (14). The LPS stock so- 
lution prepared in double-distilled water at 1-5 mg/ml was soni- 
cated for 3 rain, using a sonicator (W385; Heat-System  Ultrasonics 
Inc., Farmingdale, NY) with output control at microtip limit 8 
before being diluted into working solutions with the cell culture 
medium. 
Various concentrations of LPS were added to the macrophage 
cultures as indicated. The cells were then incubated at 37~  in 
a humidified 5% CO2 incubator for 18 h. Supematants from three 
identically treated wells were pooled and assayed  for the presence 
of TNF-c~ and NO. In all experiments in which the desensitiza- 
tion phenomenon was investigated, macrophages were pretreated 
with various subthreshold stimulatory concentrations of LPS for 
6 h, washed twice with 0.5 ml HBSS, then stimulated with the 
effective stimulatory concentration of 100 ng/ml LPS for 18 h. In 
some experiments, macrophages  were also stimulated  with 50 #g/ml 
of zymosan  (Sigma  Chemical  Co., St. Louis,  MO), heat-kiUed  Staph- 
ylococcus aureus at 50 or 250 bacteria per macrophage (generously 
provided by Dr. Chia Y. Lee, Kansas University Medical Center), 
or HKLM at 10  s to 107 bacteria/ml (generously provided by Dr. 
Judith L. Pace, Kansas University Medical Center). 
Cytotoxicity Assay  for TNF-cr Production.  The amount of  TNF-tx 
was quantitated by assessing the extent of killing of the TNF-c~- 
sensitive cell  line L929 (15). Briefly,  L929 cells were pretreated with 
5/~g/ml of actinomycin  D (Merck Sharp & Dohme, St. Louis,  MO) 
for 3 h. Macrophage  culture supernatants  were then serially  diluted 
into the L929 cell cultures in 96-weU plates (Costar Corp.), and 
the plates incubated overnight at 37~  in a humidified 5% CO2 
incubator. The viability of the L929 cells was determined  by 3-[4,5- 
dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide  (MTT) 
(Sigma Chemical  Co.) assay  (16). 1 U of  TNF-c~ activity  was defined 
by the amount of TNF-ol required to lyse 50% of the L929 cells 
in the assay. 
Analysis of Nitric Oxide (NO).  The presence of NO in macro- 
phage culture  supernatants was  determined by measuring the 
amount of nitrite, a metabolic product of NO (17). Briefly, 100 
/~1 of macrophage culture supernatant was mixed with 100 #1 of 
Griess reagent (1:1, [vol/vol] of 0.1% N-[1-naphthyl] ethylenedi- 
amine dihydrochloride [NED; Sigma Chemical Co.] in I420/1% 
sulfanilamide [Sigma Chemical Co.] in  5%  142P04) in round- 
bottomed 96-well microtiter immunoassay  plates (Dynatech Labs. 
Inc., Chantilly, VA), and the absorbance at 570 nm was measured 
on a microplate reader (MR700; Dynatech Labs. Inc.). The nitrite 
amount was calculated from a NaNO2 standard curve. 
Endotoxin Level in the Culture System.  The endotoxin levels in 
each component of complete culture medium were negative at the 
working dilution by limulus amebocyte lysate kit (sensitivity, 0.5 
EU/ml; Pyrotell, Woods Hole, MA). 
Results 
Dose-Response Profiles for LPS Stimulation  of Mouse Perito- 
nealMacrophages.  To characterize  the properties of primary 
LPS-induced downregulation of subsequent LPS-stimulated 
macrophage responses,  it  is important to define both the 
minimum and the optimal concentrations of LPS required 
for TNF-cx and NO production. E. coli 0111:B4 S-LPS was 
used to stimulate thioglycollate-elicited C3HeB/FeJ perito- 
neal macrophages. TNF-ot and NO production in the same 
culture supernatants were assessed at 18 h, and the results 
are shown in Fig. 1. Preliminary experiments indicated that 
TNF-c~ production was optimal after 2-4 h of LPS stimula- 
tion, whereas NO production was optimal after 12-18  h. 
Since TNF-c~ levels in the culture supernatants were still readily 
detectable at 18 h, assays were routindy carried out with the 
18-h culture supernatants,  so that both TNF-c~ and NO could 
be determined in the same culture supernatants. This repre- 
sentative experiment indicates that a concentration of 10 ng/ml 
of S-LPS is the threshold for effective stimulation of macro- 
phages  as  assessed by either  TNF-ol  or  NO  production, 
whereas significant responses were always observed with '~100 
ng/ml S-LPS. For all of the experiments described  in this 
manuscript, 100 ng/ml of S-LPS has been defined as the effec- 
tive stimulatory dose for macrophage activation in terms of 
TNF-c~  and NO production. 
Different Concentrations of Primary LPS Are Requirecl  for Selec- 
tive Regulation  of Subsequent LPS-stimulated  TNF-o~ and NO 
Production.  According to Mathison et al. (11), LPS-induced 
hyporesponsiveness  to  subsequent  LPS-stimulated TNF-ta 
production can be established.  In those experiments, down- 
regulation could be detected within 6 h, and reached a max- 
imum after 9 h  of exposure of procaine-elicited  peritoneal 
exudate rabbit macrophages to the primary LPS. A similar 
time course of desensitization for TNF-ot and NO produc- 
tion was observed with thioglycollate-elicited  mouse perito- 
neal macrophages in our experiments (data not shown). 
To assess the relationship between LPS-dependent NO and 
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Figure  1.  Dose responses of LPS stimulation.  Different concentrations 
orE. coli 0111:B4 S-LPS were added to thioglycoUate-elicited C3HeB/FeJ 
peritoneal  macrophage  cultures  as indicated.  After an 18-h stimulation, 
the macrophage  culture supernatants  were collected.  Supernatants  from 
three identical treatments were pooled. The results represent three similar 
experiments.  For TNF-~ production, the data shown are the average of 
duplicates; bar indicates range. The amounts of NO in the same macro- 
phage supernatants  were measured by the presence of nitrite as described 
in Materials  and Methods.  Data are triplicates  _+  SEM. 
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Figure  2.  Different concentrations of  primary LPS are required for selec- 
tive regulation  of subsequent  LPS-stimulated  TNF-c* and NO produc- 
tion. Various concentrations  of E. coli 0111:B4 S-LPS were added to the 
macrophage cultures as indicated. 6 h later, each LPS-primed macrophage 
culture was washed  twice with HBSS, then stimulated  with 100 ng/ml 
E. coli 0111:B4 S-LPS for 18 h.  The amounts of both TNF-cx and NO 
in the culture  supernatants  were assessed as described in Materials  and 
Methods.  Data for TNF-ot production are the average of duplicates; bar 
indicates range. Data for NO production are triplicates _+ SEM. The results 
are representative  of three similar experiments. 
TNF-oe production as a function of LPS pretreatment doses, 
we carried  out  experiments  in which macrophages  were 
pretreated with different subthreshold  stimulatory concen- 
trations of S-LPS for 6 h. The cells were then washed twice 
with HBSS, challenged with the effective stimulatory con- 
centration (100 ng/ml) of S-LPS for 18 h, and NO and TNF-c~ 
production from same macrophage culture supernatants were 
then assessed. The results of one such experiment are shown 
in Fig. 2. The primary dose of LPS required for the induc- 
tion of downregulation of subsequent LPS-stimulated NO 
production was 10-fold lower than those required for the in- 
duction of downregulation of the TNF-ol response. The most 
important observation in these experiments, however, is that 
when the subsequent LPS-stimulated  NO production was 
maximally reduced as a result  of pretreatment with sub- 
threshold stimulatory concentrations of LPS, the subsequent 
LPS-stimulated TNF-o~ production in the same macrophage 
cultures was optimally enhanced, and vice versa. These results 
indicate that the macrophages pretreated with LPS are not 
truly hyporesponsive  to  the subsequent  LPS  stimulation; 
rather,  they become selectively primed to respond differen- 
tially to the subsequent LPS challenge as assessed by either 
TNF-cr  or NO production. 
The LPS-induced Selective Priming Effects on Macrophage Re- 
sponses Are Not Restricted to LPS Stimulation.  To evaluate the 
specificity of the LPSqnduced selective priming effects, mac- 
rophages were preexposured to different subthreshold stimula- 
tory concentrations of primary LPS for 6 h and subsequently 
stimulated with 50/xg/ml of zymosan for 18 h. As shown 
in  Fig.  3 a,  LPS  pretreatment also modulated zymosan- 
stimulated TNF-cr and NO production. Production of TNF-o~ 
was initially enhanced and then downregulated, whereas NO 
production was initially suppressed and then enhanced. These 
results are essentially the same as noted in the earlier experi- 
ments in which LPS was used as the subsequent challenge 
stimuli (Fig. 2). The effect of LPS pretreatment on S. aureus- 
mediated stimulation of macrophages was also assessed, and 
the results are shown in Fig. 3 b. Of interest,  S. aureus, by 
itself, did not induce any NO production at any of the con- 
centrations tested. However, preexposure of the macrophages 
to subthreshold  stimulatory concentrations  of LPS primed 
the cells such that they became capable of generating NO 
when subsequently stimulated with S. aureus. LPS pretreat- 
ment also enhanced S. aureus-induced TNF-ol production at 
doses equivalent to those observed earlier for LPS stimula- 
tion (Fig. 2). Stimulation  of macrophages with heat-killed 
Listeria monocytogenes (HKLM), another Gram-positive bac- 
terium, after pretreatment of these cells with the subthreshold 
stimulatory concentrations of S-LPS for 6 h,  also resulted 
in  the  similar  enhancement/inhibition profiles  (data  not 
shown).  Therefore, these results demonstrate that the LPS 
pretreatment-induced  priming effects  on macrophage-derived 
TNF-ot and NO production are not restricted to subsequent 
LPS stimulation. 
Discussion 
Preexposure of macrophages/monocytes to subthreshold 
stimulatory doses of LPS has been known to cause down- 
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Figure  3.  The LPS-induced selective priming effects are not restricted 
to LPS stimulation. Various concentrations of E. coli 0111:B4 S-LPS were 
added to the macrophage cultures as indicated. 6 h later, each LPS-primed 
macrophage culture was washed twice with HBSS, then stimulated with 
either 50 #g/ml zymosan (a) or 50 bacteria per macrophage of S. aureus 
(b) for 18 h. The amounts of both TNF-ot and NO in the culture superna- 
tants were assessed as described in Materials and Methods. Data for TNF-o~ 
production are the average of duplicates, bar indicates range. Data for NO 
production are triplicates  +  SEM. 
regulation of LPS-dependent responses when a single mac- 
rophage response was subsequently assessed (7, 8, 11, 18, 19). 
This phenomenon has been termed "desensitization" How- 
ever, by simultaneously studying the effects of LPS pretreat- 
merit on two of the LPS-stimulated macrophage responses, 
i.e., TNF-oe and NO production, using a wide range of pri- 
mary LPS doses, we have shown that macrophage-derived 
TNF-ol production can be enhanced at the LPS primary dose 
coincident with a suppression of NO production.  Therefore, 
pretreatment of macrophages with low doses of LPS does 
not necessarily result in the macrophages becoming totally 
refractory to subsequent stimulation.  Rather, our data allow 
a somewhat different ~/iew  of the traditional concept of LPS 
desensitization: upon exposure to the subthreshold stimula- 
tory doses of LPS, macrophages become selectively primed 
or reoriented for the subsequent  stimulation.  We suggest, 
therefore, that a more appropriate terminology to define this 
phenomenon would be "LPS-induced  selective  priming effects" 
The primary dose of LPS appears to be critical for macro- 
phages to select among the potential  subsequent responses. 
The subthreshold stimulatory dose required for the upregu- 
lation  of TNF-o~ is much lower than that required for the 
downregulation of TNF-o~. The concentration of primary 
LPS used by other investigators previously in desensitization 
studies may not have been low enough to observe the en- 
hancement effect on the TNF-c~ production. 
Both TNF-oL and NO are important immune effector mol- 
ecules for macrophage-mediated  early nonspecific host re- 
sponses to nonself. We have previously shown that a G pro- 
tein inhibitor, pertussis toxin (PT), can enhance LPS-dependent 
TNF-c~ production, while under the same conditions, inhibit 
LPS-induced NO production (20). Those results suggest that 
production of TNF-oe and NO is differentially regulated in 
LPS-stimulated macrophages. Additional  experimental  evi- 
dence summarized in this manuscript would support this hy- 
pothesis. In this respect, we have shown that the primary 
LPS doses required for downregulation of TNF-c~ and NO 
production are •10-fold  different.  Further,  when macro- 
phages are primed by pretreatment with LPS so as to increase 
TNF-o~ production in response to subsequent stimulation, 
NO production is coordinately  suppressed, and vice versa. 
It would, therefore, be interesting to speculate that macro- 
phages have mechanisms to select different potential  strate- 
gies in response to nonself  when they are exposed to different 
concentrations of LPS. Upon exposure to low levels of LPS, 
the initial macrophage response would favor TNF-oe produc- 
tion. When the LPS level increases, the macrophage response 
may be switched  to generate more NO at the expense of 
TNF-o~ production. 
Primary LPS treatment can modulate zymosan-initiated 
as well as two types of Gram-positive  bacteria-stimulated mac- 
rophage responses in a similar manner as that of LPS stimu- 
lation. Similar results have recently been reported (21). There- 
fore, the LPS-induced selective priming effects would appear 
not to be mediated directly by specific  receptors for the stimuli 
used in the subsequent  challenge. Rather,  pretreatment of 
macrophages with primary LPS may initiate changes in the 
intracellular portion of the biochemical pathways selective 
for TNF-oe or NO production. It is well established that LPS- 
induced downregulation of LPS-dependent TNF-oe produc- 
tion can occur at the transcriptional level (9, 11, 12, 19), and 
that NF-KB is known to be one of the transcriptional factors 
required for initiation of TNF-ot gene expression (22, 23). 
Haas et al. (9) have recently made the interesting observation 
that Mono-Mac-6 cells pretreated with subthreshold stimula- 
tory doses of LPS were still able to induce NF-KB in the nucleus 
upon subsequent LPS challenge, although the LPS-stimulated 
TNF-o~ mRNA level was, nevertheless,  dramaticaUv  reduced. 
Considering this observation, and the results described in this 
manuscript, it is reasonable to speculate that the primary LPS 
may initiate some common steps in signal transduction, and 
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at a level subsequent to activation of transcriptional  factors, 
such as NF-xB. 
It has  been reported  that  IFN-y and TNF  synergize to 
induce NO production,  and that  anti-TNF  antibodies will 
partially suppress NO production induced by costimulation 
of murine peritoneal macrophages with IFN-3' and LPS (24). 
These results indicate that  endogenously produced TNF is 
involved in the induction of NO. However, Ding et al.  (3) 
have tested 12 cytokines for their capacity to generate NO 
and  showed  that  only IFN-y can  induce  substantial  NO 
production on its own. TNF-ot does not stimulate NO syn- 
thesis by itself, although  this cytokine could enhance IFN- 
y-induced NO production (3, 24). Further, experiments car- 
ried out in our laboratory have shown that combination of 
TNF-oe and IFN-3 also did not induce NO production by 
mouse peritoneal macrophages (X. Zhang and D. C. Mor- 
rison, unpublished observation). These results suggest that 
either IFN-y or LPS, in addition to TNF-oe, is required for 
macrophages to produce NO. Data described here have demon- 
strated that pretreatment of macrophages with subthreshold 
stimulatory concentrations of LPS enhanced subsequent LPS- 
stimulated NO production while the TNF-ot production was 
downregulated. Therefore, macrophage-derived endogenous 
TNF-oe seems not to play a role in priming macrophages in 
terms of NO production. These results support the concept 
that different mechanisms may be involved in priming  and 
stimulating macrophages to produce NO. Further studies need 
to be carried out to clarify the regulatory functions of TNF-c~ 
and IFNs in these processes. 
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